Emily Gottschalk
CIK: 0001791108
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
ANIX
Anixa Biosciences Inc
Director
Discretionary Trading P&L
Holdings
About Gottschalk Emily
Gottschalk Emily (SEC CIK 0001791108) files insider reports with the SEC as Director of Anixa Biosciences Inc (ANIX).
Signal8 holds 2 ownership filings by Gottschalk Emily, all Form 4s, filed between Jan 3, 2025 and Jan 6, 2026. Those filings report 2 transactions, from Jan 2, 2025 to Jan 5, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Gottschalk Emily's filings is in SAN JOSE,, CA.
Recent filings by Gottschalk Emily
Other insiders filing for Anixa Biosciences Inc (ANIX)
- KUMAR AMIT, Chief Executive Officer
- Titterton Lewis H jr, Director
- Baskies Arnold M, Director
- Catelani Michael, President, COO & CFO